Drugs & Pharmacology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Improving analysis practice of continuous adverse event outcomes in randomised controlled trials - a distributional approach
ConclusionWhen dichotomisation of continuous adverse event outcomes aids clinical interpretation, we advocate use of a distributional approach to retain statistical power. Methods are now easy to implement. Retaining information is especially valuable in the context of the analysis of adverse events in RCTs. The routine implementation of this automated approach requires further evaluation. (Source: Trials)
Source: Trials - June 29, 2021 Category: Research Source Type: clinical trials

Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.
Condition: Diabetes Mellitus, Type 2 Intervention: Drug: Andiabet Sponsor: Centre of Clinical Pharmacology, Hanoi Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials